Endothelial Small- and Intermediate-Conductance K Channels and Endothelium-Dependent Hyperpolarization as Drug Targets in Cardiovascular Disease

R. Köhler, A. Oliván-Viguera, Heike Wulff

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Endothelial calcium/calmodulin-gated K channels of small (KCa2.3) and intermediate conductance (KCa3.1) produce membrane hyperpolarization and endothelium-dependent hyperpolarization (EDH)-mediated vasodilation. Dysfunctions of the two channels and ensuing EDH impairments are found in several cardiovascular pathologies such as diabetes, atherosclerosis, postangioplastic neointima formation, but also inflammatory disease, cancer, and organ fibrosis. Moreover, KCa3.1 plays an important role in endothelial barrier dysfunction, edema formation in cardiac and pulmonary disease, and in ischemic stroke. Concerning KCa2.3, genome-wide association studies revealed an association of KCa2.3 channels with atrial fibrillation in humans. Accordingly, both channels are considered potential drug targets for cardio- and cerebrovascular disease states. In this chapter, we briefly review the function of the two channels in EDH-type vasodilation and systemic circulatory regulation and then highlight their pathophysiological roles in ischemic stroke as well as in pulmonary and brain edema. Finally, the authors summarize recent advances in the pharmacology of the channels and explore potential therapeutic utilities of novel channel modulators.

Original languageEnglish (US)
JournalAdvances in Pharmacology
DOIs
StateAccepted/In press - 2016

Fingerprint

Endothelium
Cardiovascular Diseases
Vasodilation
Stroke
Pharmaceutical Preparations
Cerebrovascular Disorders
Neointima
Genome-Wide Association Study
Brain Edema
Pulmonary Edema
Calmodulin
Atrial Fibrillation
Lung Diseases
Heart Diseases
Edema
Atherosclerosis
Fibrosis
Pharmacology
Pathology
Calcium

Keywords

  • Arterial dilation
  • Edema
  • Endothelium
  • Hyperpolarization
  • KCa2.3
  • KCa3.1
  • KCNN3
  • KCNN4
  • Negative-gating modulation
  • Smooth muscle
  • Vascular protection

ASJC Scopus subject areas

  • Pharmacology

Cite this

@article{ff6ceed9611349c8abd4d6b2768701d4,
title = "Endothelial Small- and Intermediate-Conductance K Channels and Endothelium-Dependent Hyperpolarization as Drug Targets in Cardiovascular Disease",
abstract = "Endothelial calcium/calmodulin-gated K channels of small (KCa2.3) and intermediate conductance (KCa3.1) produce membrane hyperpolarization and endothelium-dependent hyperpolarization (EDH)-mediated vasodilation. Dysfunctions of the two channels and ensuing EDH impairments are found in several cardiovascular pathologies such as diabetes, atherosclerosis, postangioplastic neointima formation, but also inflammatory disease, cancer, and organ fibrosis. Moreover, KCa3.1 plays an important role in endothelial barrier dysfunction, edema formation in cardiac and pulmonary disease, and in ischemic stroke. Concerning KCa2.3, genome-wide association studies revealed an association of KCa2.3 channels with atrial fibrillation in humans. Accordingly, both channels are considered potential drug targets for cardio- and cerebrovascular disease states. In this chapter, we briefly review the function of the two channels in EDH-type vasodilation and systemic circulatory regulation and then highlight their pathophysiological roles in ischemic stroke as well as in pulmonary and brain edema. Finally, the authors summarize recent advances in the pharmacology of the channels and explore potential therapeutic utilities of novel channel modulators.",
keywords = "Arterial dilation, Edema, Endothelium, Hyperpolarization, KCa2.3, KCa3.1, KCNN3, KCNN4, Negative-gating modulation, Smooth muscle, Vascular protection",
author = "R. K{\"o}hler and A. Oliv{\'a}n-Viguera and Heike Wulff",
year = "2016",
doi = "10.1016/bs.apha.2016.04.002",
language = "English (US)",
journal = "Advances in pharmacology (San Diego, Calif.)",
issn = "1054-3589",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Endothelial Small- and Intermediate-Conductance K Channels and Endothelium-Dependent Hyperpolarization as Drug Targets in Cardiovascular Disease

AU - Köhler, R.

AU - Oliván-Viguera, A.

AU - Wulff, Heike

PY - 2016

Y1 - 2016

N2 - Endothelial calcium/calmodulin-gated K channels of small (KCa2.3) and intermediate conductance (KCa3.1) produce membrane hyperpolarization and endothelium-dependent hyperpolarization (EDH)-mediated vasodilation. Dysfunctions of the two channels and ensuing EDH impairments are found in several cardiovascular pathologies such as diabetes, atherosclerosis, postangioplastic neointima formation, but also inflammatory disease, cancer, and organ fibrosis. Moreover, KCa3.1 plays an important role in endothelial barrier dysfunction, edema formation in cardiac and pulmonary disease, and in ischemic stroke. Concerning KCa2.3, genome-wide association studies revealed an association of KCa2.3 channels with atrial fibrillation in humans. Accordingly, both channels are considered potential drug targets for cardio- and cerebrovascular disease states. In this chapter, we briefly review the function of the two channels in EDH-type vasodilation and systemic circulatory regulation and then highlight their pathophysiological roles in ischemic stroke as well as in pulmonary and brain edema. Finally, the authors summarize recent advances in the pharmacology of the channels and explore potential therapeutic utilities of novel channel modulators.

AB - Endothelial calcium/calmodulin-gated K channels of small (KCa2.3) and intermediate conductance (KCa3.1) produce membrane hyperpolarization and endothelium-dependent hyperpolarization (EDH)-mediated vasodilation. Dysfunctions of the two channels and ensuing EDH impairments are found in several cardiovascular pathologies such as diabetes, atherosclerosis, postangioplastic neointima formation, but also inflammatory disease, cancer, and organ fibrosis. Moreover, KCa3.1 plays an important role in endothelial barrier dysfunction, edema formation in cardiac and pulmonary disease, and in ischemic stroke. Concerning KCa2.3, genome-wide association studies revealed an association of KCa2.3 channels with atrial fibrillation in humans. Accordingly, both channels are considered potential drug targets for cardio- and cerebrovascular disease states. In this chapter, we briefly review the function of the two channels in EDH-type vasodilation and systemic circulatory regulation and then highlight their pathophysiological roles in ischemic stroke as well as in pulmonary and brain edema. Finally, the authors summarize recent advances in the pharmacology of the channels and explore potential therapeutic utilities of novel channel modulators.

KW - Arterial dilation

KW - Edema

KW - Endothelium

KW - Hyperpolarization

KW - KCa2.3

KW - KCa3.1

KW - KCNN3

KW - KCNN4

KW - Negative-gating modulation

KW - Smooth muscle

KW - Vascular protection

UR - http://www.scopus.com/inward/record.url?scp=84964703701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964703701&partnerID=8YFLogxK

U2 - 10.1016/bs.apha.2016.04.002

DO - 10.1016/bs.apha.2016.04.002

M3 - Article

C2 - 27451095

AN - SCOPUS:84964703701

JO - Advances in pharmacology (San Diego, Calif.)

JF - Advances in pharmacology (San Diego, Calif.)

SN - 1054-3589

ER -